Literature DB >> 7898105

The ATP-dependent potassium channel: an endogenous cardioprotective mechanism.

Z Yao1, G J Gross.   

Abstract

The major objectives of the present study were to examine the effects of ischemic preconditioning and two endogenous substances, adenosine and acetylcholine (ACh), on myocardial infarct size to determine the role of the cardiac KATP channel in mediating these effects. Barbital-anesthetized open-chest dogs subjected to 60 min of left anterior descending coronary artery (LAD) occlusion followed by 4 h of reperfusion were used. Preconditioning elicited by 10 min of LAD occlusion or intracoronary infusion of adenosine (400 micrograms/min) or ACh (10 micrograms/min) for 10 min, followed by 10 min of reperfusion or drug-free period before the 60-min occlusion period, markedly reduced myocardial infarct size to a similar extent compared to that in control dogs that were infused with an equivalent volume of saline into the LAD for 10 min followed by a 10-min saline-free period before the 60-min ischemic insult. The infarct size-limiting effects of these three endogenous interventions were totally abolished by the specific KATP-channel blockers glibenclamide or 5-hydroxydecanoate. These results indicate that cardiac KATP-channel activation is an important endogenous protectant against ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7898105

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

Review 1.  ATP-sensitive potassium channels and myocardial preconditioning.

Authors:  G J Gross
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

Review 2.  Smooth Muscle Ion Channels and Regulation of Vascular Tone in Resistance Arteries and Arterioles.

Authors:  Nathan R Tykocki; Erika M Boerman; William F Jackson
Journal:  Compr Physiol       Date:  2017-03-16       Impact factor: 9.090

3.  Monophosphoryl Lipid A: A Novel Agent for Inducing Pharmacologic Myocardial Preconditioning.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

4.  Protective role of normothermic, hyperthermic and estrogen preconditioning and pretreatment on tumour necrosis factor-alpha-induced damage.

Authors:  Jasbir S Juggi; Lamia J Hoteit; Fawzi A Babiker; Shaji Joseph; Abu Salim Mustafa
Journal:  Exp Clin Cardiol       Date:  2011

5.  Block of Ca(2+)-channels by alpha-endosulphine inhibits insulin release.

Authors:  Anne Virsolvy; Paul Smith; Gyslaine Bertrand; Laurent Gros; Lisa Héron; Guillermo Salazar; Raymond Puech; Dominique Bataille
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning.

Authors:  Norihito Sasaki; Mitsushige Murata; Yiru Guo; Su-Hyun Jo; Andreas Ohler; Masaharu Akao; Brian O'Rourke; Rui-Ping Xiao; Roberto Bolli; Eduardo Marbán
Journal:  Circulation       Date:  2003-03-04       Impact factor: 29.690

7.  Activation of cardiac muscarinic M3 receptors induces delayed cardioprotection by preserving phosphorylated connexin43 and up-regulating cyclooxygenase-2 expression.

Authors:  Jinlong Zhao; Yue Su; Yong Zhang; Zhenwei Pan; Lili Yang; Xichuang Chen; Yan Liu; Yanjie Lu; Zhimin Du; Baofeng Yang
Journal:  Br J Pharmacol       Date:  2010-02-01       Impact factor: 8.739

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.